Navigation Links
PRA International Speaking Event: Beyond Global Feasibility
Date:3/19/2009

An Evidence-Based Approach to Creating Realistic Development Timelines

RALEIGH, N.C., March 19 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces its Senior Vice President of Scientific and Medical Affairs, Kent Thoelke, will host a webinar on optimizing site and country selection. The webinar will take place on March 25, 2009 at 11:30 am ET.

Mr. Thoelke will discuss how to mitigate one of the greatest risks for successful drug development: delayed clinical development timelines. Detailed planning and appropriate site and country selection are the most critical factors in meeting target patient accrual goals within the planned timeline. Mr. Thoelke will explore how an evidence-based approach, coupled with survey based feasibility provides the most accurate forecast for patient accrual and the selection of sites and countries with the highest likelihood of being productive.

With PRA since 2006, Mr. Thoelke has over 19 years of experience in the global drug development and device industry, holding positions in both clinical and corporate development in multinational R&D companies, as well as small and emerging biotechnology companies. As part of the PRA Leadership Team, Mr. Thoelke provides high-level strategic oversight of product development, supporting PRA teams that are executing studies for Sponsors. Having visited over 40 countries, he is very familiar with the global drug development environment, and has established relationships with therapeutic experts in numerous indications around the world. Mr. Thoelke has spoken widely regarding the current landscape of clinical trial recruitment and its effect on drug development timelines. He is active in pursuing novel technologies and strategies to move the current clinical drug development paradigm away from anecdotal strategy to a more focused evidence-based strategy.

The deadline for registration is Tuesday March 24, 2009. Registration information can be found at: http://www.fxconferences.com/Beyond-Global-Feasibility-An-Evidence-Based-Approach-to-Creating-Realistic-Development-Timelines-P300.aspx .

About PRA International

PRA International is a global Clinical Research Organization providing services through all phases of clinical development. Although we specialize in Oncology, CNS, Respiratory/Allergy, Cardiovascular and Infectious Diseases, we perform studies in all therapeutic areas. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge, enable our project teams to deliver consistent and on time performance for our clients.

To learn more about PRA International, please visit http://www.prainternational.com, email endpoints@praintl.com or call our Global Headquarters at +1 (919) 786-8200.


'/>"/>
SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Toxic Chemicals in Childrens Bath Products Trigger International Outcry
2. Barriers to diabetes care include restaurants and high-risk lifestyles, says international review
3. Valeant Pharmaceuticals Appoints President of Valeant Pharmaceuticals International
4. International Trachoma Initiative and the Task Force for Child Survival and Development Announce New Merger to Eliminate Blinding Trachoma and Fight Against Other Neglected Tropical Diseases
5. Mobile Massage Team Attending International Special Events Society Greater Philadelphia Chapter Industry Showcase - FRESH! 2009
6. Siemens to Donate Hearing Instruments Through Second Annual Partnership With Quota International
7. Relsys International Announces the Release of the Argus Safety(TM) Suite 5.0
8. DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008
9. Irish-Owned Heritage Casket Company Strikes Multi-Million-Dollar Partnership Deal With Pennsylvanias Matthews International
10. AJWS Asks International Community to Demand Reinstatement of International Aid Groups Into Sudan
11. Clinical Care Options and NAM Selected by the International AIDS Society to Collaborate on Official Online Conference Coverage From Annual Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: